BSEInsider Trading / SAST3d ago · 17 Aug 2026, 03:05 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alkesh Mahasukhlal Gopani & Others
Parmax Pharma Ltd · 540359
✦ AI SummaryRelated Party
Parmax Pharma Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Alkesh Mahasukhlal Gopani & Others, indicating a potential change in shareholding.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk4/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011